SMITHKLINE BIOLOG has a total of 106 patent applications. Its first patent ever was published in 1983. It filed its patents most often in Portugal, Australia and United Kingdom. Its main competitors in its focus markets biotechnology, pharmaceuticals and environmental technology are MG PMC LLC, SHANDONG XINRUI BIOTECHNOLOGY CO LTD and GILL PARKASH S.
# | Country | Total Patents | |
---|---|---|---|
#1 | Portugal | 13 | |
#2 | Australia | 9 | |
#3 | United Kingdom | 7 | |
#4 | Ireland | 7 | |
#5 | United States | 6 | |
#6 | Denmark | 5 | |
#7 | EPO (European Patent Office) | 5 | |
#8 | Israel | 5 | |
#9 | New Zealand | 5 | |
#10 | South Africa | 5 | |
#11 | Greece | 4 | |
#12 | Hungary | 4 | |
#13 | Norway | 4 | |
#14 | German Democratic Republic | 3 | |
#15 | Finland | 3 | |
#16 | Japan | 3 | |
#17 | Morocco | 3 | |
#18 | Canada | 2 | |
#19 | Hong Kong | 2 | |
#20 | Republic of Korea | 2 | |
#21 | African Regional Industrial Property Organization | 1 | |
#22 | Argentina | 1 | |
#23 | China | 1 | |
#24 | Cyprus | 1 | |
#25 | Egypt | 1 | |
#26 | African Intellectual Property Organization | 1 | |
#27 | USSR (Union of Socialist Soviet Republics) | 1 | |
#28 | WIPO (World Intellectual Property Organization) | 1 | |
#29 | Yugoslavia (Serbia and Montenegro) | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Environmental technology | |
#4 | Machines | |
#5 | Measurement |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Microorganisms | |
#3 | Medical preparations | |
#4 | Therapeutic chemical compounds | |
#5 | Climate change adaptation technologies | |
#6 | Unspecified technologies | |
#7 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Cabezon Teresa | 21 |
#2 | Harford Nigel | 20 |
#3 | Jacobs Eric | 18 |
#4 | Massaer Marc | 15 |
#5 | Jacobs Paul | 15 |
#6 | Rutgers Apolonia | 14 |
#7 | Comberbach Martin | 13 |
#8 | Heinderyckx Michel | 13 |
#9 | Bollen Alex | 13 |
#10 | Merckelbach Armin J | 12 |
Publication | Filing date | Title |
---|---|---|
GB0112214D0 | Novel compounds | |
GB0112211D0 | Novel compounds | |
GB9808571D0 | Novel compounds | |
GB9724531D0 | Novel compounds | |
GB9021175D0 | Novel compounds | |
ZA9005763B | Novel antigens and methods therefor | |
EP0414374A2 | Novel antigens and methods for their preparation | |
GB9015866D0 | Vectors | |
GB9015888D0 | Vectors | |
IE894106L | Expression of the plasmodium circumsporozite protein in¹insects | |
EP0409923A1 | EXPRESSION OF THE i(PLASMODIUM) CIRCUMSPOROZOITE PROTEIN IN INSECT CELLS | |
IE892389L | Hiv diagnostic method and agent | |
AU3885489A | Hiv diagnostic method and reagent | |
IE892369L | Bordetella pertussis vaccine | |
AP8900132A0 | Bordetella pertussis vaccine | |
JPH0349686A | Expression of retrovirus gag protein in eukaryotic cell | |
IE891750L | Expression of retrovirus gag protein in eukaryotic cells | |
IL90381D0 | Expression of retrovirus gag protein in eukaryotic cells | |
DK643188D0 | Expression of hiv proteins in e.coli and s.cerevisiae | |
PT88556A | Process of stable and expression genomic integration of a strange, black metallic sequence |